Correlation of mycophenolic acid pharmacokinetic parameters with side effects in chinese kidney transplant recipients treated with mycophenolate mofetil

被引:13
作者
Lu, YP
Lin, B
Liang, MZ
Wang, L
Nan, F
Yu, Q
Tang, KS
机构
[1] Sichuan Univ, W China Hosp, Inst Transplantat, Chengdu 610041, Peoples R China
[2] Sichuan Univ, W China Hosp, Dept Clin Pharmacol, Chengdu 610041, Peoples R China
关键词
D O I
10.1016/j.transproceed.2004.07.042
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2079 / 2081
页数:3
相关论文
共 9 条
  • [1] GRINYO J, 1995, LANCET, V345, P1321
  • [2] Hübner GI, 2000, ARZNEIMITTELFORSCH, V50, P936
  • [3] Keown P, 1996, TRANSPLANTATION, V61, P1029
  • [4] Drug monitoring of mycophenolic acid in the early period after renal transplantation
    Krumme, B
    Wollenberg, K
    Kirste, G
    Schollmeyer, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1773 - 1774
  • [5] Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients -: Is it necessary?
    Mourad, M
    Wallemacq, P
    König, J
    de Frahan, EH
    Eddour, DC
    De Meyer, M
    Malaise, J
    Squifflet, JP
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (05) : 319 - 327
  • [6] Mourad M, 2001, CLIN CHEM, V47, P88
  • [7] MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
    SOLLINGER, HW
    [J]. TRANSPLANTATION, 1995, 60 (03) : 225 - 232
  • [8] A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
    van Gelder, T
    Hilbrands, LB
    Vanrenterghem, Y
    Weimar, W
    de Fijter, JW
    Squifflet, JP
    Hené, RJ
    Verpooten, GA
    Navarro, MT
    Hale, MD
    Nicholls, AJ
    [J]. TRANSPLANTATION, 1999, 68 (02) : 261 - 266
  • [9] Weber LT, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133759